Entropy Technologies’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Entropy Technologies's DGX Position: Q2 2026 in Review
Entropy Technologies opened a new position in Quest Diagnostics (DGX) in Q2 2026: 5,779 shares worth $1.22M. The stake represents 0.05% of the portfolio and ranks #460 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in DGX as recently as Q4 2025.
Entropy Technologies first reported a position in DGX in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.97M in Q4 2025. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Entropy Technologies held 5,779 shares of Quest Diagnostics worth $1.22M as of Q2 2026.
- Quest Diagnostics was a new Entropy Technologies position in Q2 2026.
- Quest Diagnostics made up 0.05% of Entropy Technologies's portfolio in Q2 2026, its #460 holding.
- Entropy Technologies first reported a position in Quest Diagnostics in Q4 2023 and has held it in 5 quarters since.
- Entropy Technologies's Quest Diagnostics position peaked at $1.97M in Q4 2025.
- 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.